Obstructive Airway Diseases
Role of Lipid Mediators
CHF 86.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V112:
Lieferbar in ca. 10-20 Arbeitstagen
Produktdetails
Weitere Autoren: Srivastava, Punit Kumar (Hrsg.)
- ISBN: 978-1-138-37445-4
- EAN: 9781138374454
- Produktnummer: 29781608
- Verlag: Taylor and Francis
- Sprache: Englisch
- Erscheinungsjahr: 2018
- Seitenangabe: 381 S.
- Masse: H23.4 cm x B15.6 cm 710 g
- Abbildungen: Farb., s/w. Abb.
- Gewicht: 710
Über den Autor
Abhijit Ray has worked in human trials with molecules designed to treat airway inflammation associated with asthma and COPD and has published more than 60 articles in peer-reviewed journals. He has been the senior director and head of biology research at Daiichi Sankyo Life Science Research Centre India, Gurgaon since July 2010. As a member of the drug discovery team, he manages a group of 60 scientists engaged in discovery research for drugs in the areas of infectious and inflammatory diseases.Punit Srivastava has been a group leader of biology at Daiichi Sankyo Life Science Research Centre India, Gurgaon since July 2010. He was a member of the drug discovery group of Ranbaxy Laboratories Ltd. from 2004 to June 2010 and has worked for more than six years in drug discovery research, which has resulted in one molecule entering human trial for COPD. He has published more than 15 articles in peer-reviewed journals and filed at least six patents. As a member of the drug discovery team at Daiichi Sankyo, he is leading projects in the area of inflammation.
2 weitere Werke von Abhijit (Hrsg.) Ray:
Bewertungen
Anmelden